AAAAAA

   
Results: 1-11 |
Results: 11
Clinical validation of a new dimeric inhibin-A assay suitable for second trimester Down's syndrome screening
Authors: Knight, GJ Palomaki, GE Neveux, LM Haddow, JE Lambert-Messerlian, GM
Citation: Gj. Knight et al., Clinical validation of a new dimeric inhibin-A assay suitable for second trimester Down's syndrome screening, J MED SCREE, 8(1), 2001, pp. 2-7
Second-trimester levels of maternal serum human chorionic gonadotropin andinhibin A as predictors of preeclampsia in the third trimester of pregnancy
Authors: Lambert-Messerlian, GM Silver, HM Petraglia, F Luisi, S Pezzani, I Maybruck, WM Hogge, WA Hanley-Yanez, K Roberts, JM Neveux, LM Canick, JA
Citation: Gm. Lambert-messerlian et al., Second-trimester levels of maternal serum human chorionic gonadotropin andinhibin A as predictors of preeclampsia in the third trimester of pregnancy, J SOC GYN I, 7(3), 2000, pp. 170-174
Participation in maternal serum screening following screen positive results in a previous pregnancy
Authors: Rausch, DN Lambert-Messerlian, GM Canick, JA
Citation: Dn. Rausch et al., Participation in maternal serum screening following screen positive results in a previous pregnancy, J MED SCREE, 7(1), 2000, pp. 4-6
Is inhibin a serum marker for ovarian cancer?
Authors: Lambert-Messerlian, GM
Citation: Gm. Lambert-messerlian, Is inhibin a serum marker for ovarian cancer?, EUR J ENDOC, 142(4), 2000, pp. 331-333
Second trimester levels of maternal serum inhibin A in pregnancies affected by fetal neural tube defects
Authors: Lambert-Messerlian, GM Palomaki, GE Canick, JA
Citation: Gm. Lambert-messerlian et al., Second trimester levels of maternal serum inhibin A in pregnancies affected by fetal neural tube defects, PRENAT DIAG, 20(8), 2000, pp. 680-682
High maternal serum inhibin A levels following the loss of one fetus in a twin pregnancy
Authors: Goodwin, KM Sweeney, PJ Lambert-Messerlian, GM Canick, JA
Citation: Km. Goodwin et al., High maternal serum inhibin A levels following the loss of one fetus in a twin pregnancy, PRENAT DIAG, 20(12), 2000, pp. 1015-1017
Participation in maternal serum screening for Down syndrome, neural tube defects, and trisomy 18 following screen-positive results in a previous pregnancy
Authors: Rausch, DN Lambert-Messerlian, GM Canick, JA
Citation: Dn. Rausch et al., Participation in maternal serum screening for Down syndrome, neural tube defects, and trisomy 18 following screen-positive results in a previous pregnancy, WEST J MED, 173(3), 2000, pp. 180-183
Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnancies
Authors: Phipps, MG Hogan, JW Peipert, JF Lambert-Messerlian, GM Canick, JA Seifer, DB
Citation: Mg. Phipps et al., Progesterone, inhibin, and hCG multiple marker strategy to differentiate viable from nonviable pregnancies, OBSTET GYN, 95(2), 2000, pp. 227-231
Second-trimester maternal serum progesterone levels in Turner syndrome with and without hydrops and in trisomy 18
Authors: Lambert-Messerlian, GM Saller, DN Tumber, MB French, CA Peterson, CJ Canick, JA
Citation: Gm. Lambert-messerlian et al., Second-trimester maternal serum progesterone levels in Turner syndrome with and without hydrops and in trisomy 18, PRENAT DIAG, 19(5), 1999, pp. 476-479
Secretion of activin A in recurrent epithelial ovarian carcinoma
Authors: Lambert-Messerlian, GM DePasquale, SE Maybruck, WM Steinhoff, MM Gajewski, WH
Citation: Gm. Lambert-messerlian et al., Secretion of activin A in recurrent epithelial ovarian carcinoma, GYNECOL ONC, 74(1), 1999, pp. 93-97
Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies
Authors: Silver, HM Lambert-Messerlian, GM Star, JA Hogan, J Canick, JA
Citation: Hm. Silver et al., Comparison of maternal serum total activin A and inhibin A in normal, preeclamptic, and nonproteinuric gestationally hypertensive pregnancies, AM J OBST G, 180(5), 1999, pp. 1131-1137
Risultati: 1-11 |